www.sec.gov/Archives/edgar/data/882291/0001019687-05-00 -
[Cached Version]
Published on: 7/14/2005
Last Visited: 3/27/2006
We believe that all filing requirements applicable to its officers, directors, and greater than 10% beneficial owners were complied with, except Mr. Calvin Leung, one of our directors, filed a late Form 4 reporting the award of stock options to purchase 339,400 shares of our common stock.
...
(4) Effective June 30, 2003, Mr. Leung was elected to our Board of Directors.
...
Calvin M. Leung
...
Mr. Leung became a director of Aethlon Medical on June 30, 2003.He is the President of Mandarin Investment Corporation, specializing in investment, development and management of mobile home and recreational vehicle parks in California, Arizona and the Midwest since 1975.He has syndicated a number of land and housing developments in the western United States.
Mr. Leung, born in Hong Kong, received his advanced education in the United States where he was awarded a doctorate degree in psychology specializing in experimental research.He taught at the university level for several years.
Our Board of Directors has the responsibility for establishing broad corporate policies and for overseeing our overall performance.Members of the Board are kept informed of our business activities through discussions with the President and other officers, by reviewing analyses and reports sent to them, and by participating in Board and committee meetings.Our bylaws provide that each of the directors serves for a term that extends to the next Annual Meeting of Shareholders of the Company.Our Board of Directors presently has an Audit Committee and a Compensation Committee on each of which Messrs.Barry, Broenniman and Leung serve.